{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220909",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "72074",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761148Orig1s000Corrected_ltr.pdf",
              "date": "20220913",
              "type": "Letter"
            },
            {
              "id": "72089",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761148Orig1s000Corrected_lbl.pdf",
              "date": "20220916",
              "type": "Label"
            },
            {
              "id": "72293",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/761148Orig1s000TOC.html",
              "date": "20221011",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20251212",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "84436",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761148Orig1s011ltr.pdf",
              "date": "20251218",
              "type": "Letter"
            },
            {
              "id": "84437",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761148Orig1s011lbl.pdf",
              "date": "20251218",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20230616",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "74540",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761148Orig1s002ltr.pdf",
              "date": "20230620",
              "type": "Letter"
            },
            {
              "id": "74546",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761148s002lbl.pdf",
              "date": "20230620",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761148",
      "sponsor_name": "SPECTRUM PHARMS",
      "openfda": {
        "application_number": [
          "BLA761148"
        ],
        "brand_name": [
          "ROLVEDON"
        ],
        "generic_name": [
          "EFLAPEGRASTIM-XNST"
        ],
        "manufacturer_name": [
          "Spectrum Pharmaceuticals, Inc.",
          "Assertio Specialty Pharmaceuticals, LLC"
        ],
        "product_ndc": [
          "76961-101",
          "82497-132"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "EFLAPEGRASTIM"
        ],
        "rxcui": [
          "2612541",
          "2612547"
        ],
        "spl_id": [
          "9209fc63-aee3-43dc-9bc6-16c5ed73d858",
          "ef8eef01-b278-484e-b4d4-85905e756674"
        ],
        "spl_set_id": [
          "6e436115-62e7-4729-aeb0-ff78ea685206",
          "2dc62c46-bb10-4a62-a459-d3eeeb6dd82f"
        ],
        "package_ndc": [
          "76961-101-01",
          "82497-132-01"
        ],
        "nui": [
          "M0024696",
          "N0000009451",
          "N0000175666"
        ],
        "pharm_class_cs": [
          "Granulocyte Colony-Stimulating Factor [CS]"
        ],
        "pharm_class_pe": [
          "Increased Myeloid Cell Production [PE]"
        ],
        "pharm_class_epc": [
          "Leukocyte Growth Factor [EPC]"
        ],
        "unii": [
          "UT99UG9QJX"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "ROLVEDON",
          "active_ingredients": [
            {
              "name": "EFLAPEGRASTIM-XNST",
              "strength": "13.2MG/0.6ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}